Michael Mullan
MD, PhD
Executive Director
Biography
Dr. Mullan trained both as a physician, treating patients with neuropsychiatric diseases, and also as a neuroscientist. He has authored over 300 scientific publications on Alzheimer’s Disease and other neurological disorders and focuses on finding new treatments for them.
Recent Publications
Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor
Authors: Jiazhi Sun, Michelle A Blaskovich, Rishi K Jain, Frederic Delarue, Daniel Paris, Steven Brem, Marguerite Wotoczek-Obadia, Qing Lin, Domenico Coppola, Kihang Choi, Michael Mullan, Andrew D Hamilton, and Saïd M Sebti
Publish Date: May 17, 2026
Targeting dual specificity tyrosine-phosphorylation-regulated kinase 1A mitigates tauopathy and enhances recovery after repetitive head injury
Authors: Benoit Melchior, Mackenzie Browning, Robyn McCartan, Carolyn Lai, Coral Hahn-Townsend, Arissa Gratkowski, Alexander Morin, Michael Mullan, Fiona Crawford, Mirta Grifmana, and Benoit Mouzon
Publish Date: February 5, 2026
Oleoylethanolamide supplementation improves mood and reduces fatigue in veterans with GWI in a 15-week randomized, double-blind, placebo-controlled exploratory clinical trial
Authors: Laila Abdullah, Andrew P. Keegan, Michael Hoffmann, James Baraniuk, Wendy Mack, Kimberly Sullivan, Cheryl Luis, Cheryl Rindfleisch, Claire J.C. Huguenard, Adam Cseresznye, Gregory J. Aldrich, James E. Evans, Daniel Paris, Dakota Helgager, Fiona Crawford, and Michael Mullan
Publish Date: January 9, 2026
Prophylactic treatment with amnion progenitor cell secretome mitigates traumatic optic neuropathy
Authors: Mackenzie Browning, Robyn McCartan, Arissa Gratkowski, Daniel Paris, Andrew Pearson, Alexander Morin, Scott Ferguson, Larry Brown, Howard Wessel, Radouil Tzekov, Michael Mullan, Fiona Crawford, and Benoit Mouzon
Publish Date: October 10, 2025